VIMTA LABS
|
The Current P/E Ratio of VIMTA LABS is 30.91.
| Share Price | ₹409.2 | Apr 02,2026 |
| Market Cap | ₹1,828.9 Cr | |
| Earnings-TTM | ₹59.2 Cr | TTM-Consolidated Results |
| Price/Earnings | 30.91x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of VIMTA LABS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹1,828.9 Cr] as on Apr 02,2026
(/) Earnings [ ₹59.2 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 30.91x ]
Thus, for VIMTA LABS , the investors are currently willing to pay 30.91 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of VIMTA LABS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of VIMTA LABS over the last five years.
Historical PE (Price/Earnings) ratio chart of VIMTA LABS
PE Ratio Performance Analysis for VIMTA LABS
- VIMTA LABS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 18.22x.
- VIMTA LABS 's operated at median p/e ratio of 16.86x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, VIMTA LABS 's p/e ratio peaked in Mar2024 at 24.04x.
- VIMTA LABS 's p/e ratio hit its five-year low in Mar2023 of 14.44x.
How does VIMTA LABS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| VIMTA LABS | 59.16 | 30.91 | 1,828.9 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,001.40 | 36.96 | 406,603.0 |
| DIVIS LABORATORIES LTD | 2,479.00 | 62.72 | 155,485.0 |
| CIPLA LTD | 4,544.70 | 21.21 | 96,400.8 |
| TORRENT PHARMACEUTICALS LTD | 2,272.00 | 59.42 | 135,009.0 |
| DR REDDYS LABORATORIES LTD | 5,508.70 | 18.45 | 101,628.0 |
| MANKIND PHARMA LTD | 1,796.65 | 45.90 | 82,460.4 |
| ZYDUS LIFESCIENCES LTD | 4,933.90 | 17.63 | 86,963.8 |
| LUPIN LTD | 4,669.18 | 22.29 | 104,091.0 |
| AUROBINDO PHARMA LTD | 3,513.20 | 22.09 | 77,592.2 |
| ABBOTT INDIA LTD | 1,524.13 | 36.63 | 55,833.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs VIMTA LABS 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 17.63x |
| Max industry PE | 62.72x |
| Median industry PE | 30.91x |
| Average industry PE | 34.02x |
You may also like the below Video Courses